Discover
CHRS
Coherus Oncology, Inc.
1.20
5 x 1.14
1 x 1.21
bid
ask
+
0.06
5.26%
2 @ 04:00 PM
1.21 +0.01 (0.83%)
| Ytd | -15.49% | |
| 1y | 17.65% |
1.14
day range
1.20
1.02
52 week range
2.51
| Open | 1.17 | Prev Close | 1.14 | Low | 1.14 | High | 1.20 | Mkt Cap | 185.40M |
| Vol | 636.08K | Avg Vol | 961.30K | EPS | -1.11 | P/E | -1.08 | Forward P/E | -5.30 |
| Beta | 0.69 | Short Ratio | 8.43 | Inst. Own | 70.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 1.43 | 200-d Avg | 1.58 | 1yr Est | 5.90 |
| Income Statement | |||
| Total Revenue | 14.31M | ||
| Revenues (USD) | 14.31M | ||
| Cost of Revenue | 4.24M | ||
| Gross Profit | 10.07M | ||
| Operating Expenses | 42.40M | ||
| Research and Development Expense | 21.44M | ||
| Selling, General and Administrative Expense | 20.95M | ||
| Operating Income | -32.33M | ||
| Interest Expense | 2.32M | ||
| Net Income | -20.63M | ||
| Net Income Common Stock | -20.63M | ||
| Net Income Common Stock (USD) | -20.63M | ||
| Consolidated Income | -20.63M | ||
| Net Income from Discontinued Operations | -12.72M | ||
| Earnings per Basic Share | -0.13 | ||
| Earnings per Basic Share (USD) | -0.13 | ||
| Earnings per Diluted Share | -0.13 | ||
| Earning Before Interest & Taxes (EBIT) | -18.31M | ||
| Earning Before Interest & Taxes (USD) | -18.31M | ||
| Weighted Average Shares | 154.82M | ||
| Weighted Average Shares Diluted | 154.82M | ||
| Balance Sheet | |||
| Cash and Equivalents | 82.92M | ||
| Cash and Equivalents (USD) | 82.92M | ||
| Investments | 22.38M | ||
| Investments Current | 22.38M | ||
| Trade and Non-Trade Receivables | 14.25M | ||
| Current Assets | 133.79M | ||
| Property, Plant & Equipment Net | 865.00K | ||
| Total Assets | 191.18M | ||
| Total Debt | 37.25M | ||
| Current Liabilities | 75.51M | ||
| Debt Non-Current | 37.25M | ||
| Total Liabilities | 130.35M | ||
| Accumulated Retained Earnings (Deficit) | -1.44B | ||
| Accumulated Other Comprehensive Income | -281.00K | ||
| Shareholders Equity | 60.84M | ||
| Shareholders Equity (USD) | 60.84M | ||
| Assets Non-Current | 57.40M | ||
| Total Debt (USD) | 37.25M | ||
| Goodwill and Intangible Assets | 44.99M | ||
| Inventory | 14.09M | ||
| Liabilities Non-Current | 54.84M | ||
| Trade and Non-Trade Payables | 35.83M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 862.00K | ||
| Net Cash Flow from Financing | 144.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -32.31M | ||
| Issuance (Purchase) of Equity Shares | 202.00K | ||
| Issuance (Repayment) of Debt Securities | -121.00K | ||
| Net Cash Flow from Investing | 29.63M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 29.64M | ||
| Net Cash Flow from Operations | -62.09M | ||
| Share Based Compensation | 2.58M | ||